605 related articles for article (PubMed ID: 19620501)
21. Predictors and Long-Term Clinical Impact of Acute Stent Malapposition: An Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents (ADAPT-DES) Intravascular Ultrasound Substudy.
Wang B; Mintz GS; Witzenbichler B; Souza CF; Metzger DC; Rinaldi MJ; Duffy PL; Weisz G; Stuckey TD; Brodie BR; Matsumura M; Yamamoto MH; Parvataneni R; Kirtane AJ; Stone GW; Maehara A
J Am Heart Assoc; 2016 Dec; 5(12):. PubMed ID: 28007741
[TBL] [Abstract][Full Text] [Related]
22. OCT analysis in patients with very late stent thrombosis.
Kang SJ; Lee CW; Song H; Ahn JM; Kim WJ; Lee JY; Park DW; Lee SW; Kim YH; Mintz GS; Park SW; Park SJ
JACC Cardiovasc Imaging; 2013 Jun; 6(6):695-703. PubMed ID: 23643282
[TBL] [Abstract][Full Text] [Related]
23. Incidence, mechanisms, predictors, and clinical impact of acute and late stent malapposition after primary intervention in patients with acute myocardial infarction: an intravascular ultrasound substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial.
Guo N; Maehara A; Mintz GS; He Y; Xu K; Wu X; Lansky AJ; Witzenbichler B; Guagliumi G; Brodie B; Kellett MA; Dressler O; Parise H; Mehran R; Stone GW
Circulation; 2010 Sep; 122(11):1077-84. PubMed ID: 20805433
[TBL] [Abstract][Full Text] [Related]
24. Impact of late incomplete stent apposition after sirolimus-eluting stent implantation on 4-year clinical events: intravascular ultrasound analysis from the multicentre, randomised, RAVEL, E-SIRIUS and SIRIUS trials.
Hoffmann R; Morice MC; Moses JW; Fitzgerald PJ; Mauri L; Breithardt G; Schofer J; Serruys PW; Stoll HP; Leon MB
Heart; 2008 Mar; 94(3):322-8. PubMed ID: 17761505
[TBL] [Abstract][Full Text] [Related]
25. Acute coronary syndrome is an independent risk factor for late incomplete stent apposition after sirolimus-eluting stent implantation.
Zhang RY; DU R; Zhu ZB; Zhang Q; Hu J; Lü AK; Zhang JS; Shen WF
Chin Med J (Engl); 2008 Dec; 121(24):2504-8. PubMed ID: 19187586
[TBL] [Abstract][Full Text] [Related]
26. Intravascular ultrasound results from the ENDEAVOR IV trial: randomized comparison between zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease.
Waseda K; Miyazawa A; Ako J; Hasegawa T; Tsujino I; Sakurai R; Yock PG; Honda Y; Kandzari DE; Leon MB; Fitzgerald PJ;
JACC Cardiovasc Interv; 2009 Aug; 2(8):779-84. PubMed ID: 19695548
[TBL] [Abstract][Full Text] [Related]
27. Late incomplete apposition after drug-eluting stent implantation: incidence and potential for adverse clinical outcomes.
Siqueira DA; Abizaid AA; Costa Jde R; Feres F; Mattos LA; Staico R; Abizaid AA; Tanajura LF; Chaves A; Centemero M; Sousa AG; Sousa JE
Eur Heart J; 2007 Jun; 28(11):1304-9. PubMed ID: 17478457
[TBL] [Abstract][Full Text] [Related]
28. Stent thrombosis after sirolimus- and paclitaxel-eluting stent implantation in daily clinical practice: analysis of a single center registry.
Trabattoni D; Fabbiocchi F; Montorsi P; Ravagnani P; Galli S; Teruzzi G; Calligaris G; De Martini S; Bartorelli AL
Catheter Cardiovasc Interv; 2007 Sep; 70(3):415-21. PubMed ID: 17722020
[TBL] [Abstract][Full Text] [Related]
29. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials.
Bangalore S; Kumar S; Fusaro M; Amoroso N; Attubato MJ; Feit F; Bhatt DL; Slater J
Circulation; 2012 Jun; 125(23):2873-91. PubMed ID: 22586281
[TBL] [Abstract][Full Text] [Related]
30. Coronary evaginations are associated with positive vessel remodelling and are nearly absent following implantation of newer-generation drug-eluting stents: an optical coherence tomography and intravascular ultrasound study.
Radu MD; Räber L; Kalesan B; Muramatsu T; Kelbæk H; Heo J; Jørgensen E; Helqvist S; Farooq V; Brugaletta S; Garcia-Garcia HM; Jüni P; Saunamäki K; Windecker S; Serruys PW
Eur Heart J; 2014 Mar; 35(12):795-807. PubMed ID: 24132187
[TBL] [Abstract][Full Text] [Related]
31. Coronary arterial remodeling and out-stent plaque change after drug-eluting stent implantation--comparison between zotarolimus-eluting stents and paclitaxel-eluting stents.
Muraoka Y; Sonoda S; Kashiyama K; Kamezaki F; Tsuda Y; Araki M; Tamura M; Takeuchi M; Abe H; Okazaki M; Otsuji Y
Circ J; 2013; 77(2):363-71. PubMed ID: 23117679
[TBL] [Abstract][Full Text] [Related]
32. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial.
Kim JS; Jang IK; Fan C; Kim TH; Kim JS; Park SM; Choi EY; Lee SH; Ko YG; Choi D; Hong MK; Jang Y
JACC Cardiovasc Interv; 2009 Dec; 2(12):1240-7. PubMed ID: 20129551
[TBL] [Abstract][Full Text] [Related]
33. Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials.
De Luca G; Dirksen MT; Spaulding C; Kelbaek H; Schalij M; Thuesen L; van der Hoeven B; Vink MA; Kaiser C; Musto C; Chechi T; Spaziani G; Díaz de la Llera LS; Pasceri V; Di Lorenzo E; Violini R; Cortese G; Suryapranata H; Stone GW;
Arch Intern Med; 2012 Apr; 172(8):611-21; discussion 621-2. PubMed ID: 22529227
[TBL] [Abstract][Full Text] [Related]
34. Risk of late-acquired incomplete stent apposition after drug-eluting stent versus bare-metal stent. A meta-analysis from 12 randomized trials.
Sanchez-Recalde A; Moreno R; Barreales L; Rivero F; Galeote G; Jimenez-Valero S; Calvo L; López de Sá E; López-Sendón JL
J Invasive Cardiol; 2008 Aug; 20(8):417-22. PubMed ID: 18688067
[TBL] [Abstract][Full Text] [Related]
35. Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.
Palmerini T; Biondi-Zoccai G; Della Riva D; Mariani A; Sabaté M; Smits PC; Kaiser C; D'Ascenzo F; Frati G; Mancone M; Genereux P; Stone GW
J Am Coll Cardiol; 2014 Feb; 63(4):299-307. PubMed ID: 24211507
[TBL] [Abstract][Full Text] [Related]
36. Impact of preinterventional plaque composition and eccentricity on late-acquired incomplete stent apposition after sirolimus-eluting stent implantation: an intravascular ultrasound radiofrequency analysis.
Sato T; Kameyama T; Noto T; Nozawa T; Inoue H
Coron Artery Dis; 2012 Nov; 23(7):432-7. PubMed ID: 22936019
[TBL] [Abstract][Full Text] [Related]
37. Presence of older thrombus in patients with late and very late drug-eluting stent thrombosis.
Nishihira K; Hatakeyama K; Kuriyama N; Nomura K; Fukushima Y; Inoue Y; Nakama T; Mine D; Sagara S; Ashikaga K; Matsuyama A; Kitamura K; Shibata Y; Asada Y
J Cardiol; 2012 Jan; 59(1):57-63. PubMed ID: 22019274
[TBL] [Abstract][Full Text] [Related]
38. Intravascular ultrasound assessment of postprocedural incomplete stent apposition.
Kume T; Waseda K; Ako J; Sakata K; Yamasaki M; Shimohama T; Tsujino I; Hasegawa T; Fitzgerald PJ; Honda Y
J Invasive Cardiol; 2012 Jan; 24(1):13-6. PubMed ID: 22210583
[TBL] [Abstract][Full Text] [Related]
39. Successful treatment of very late drug-eluting stent thrombosis using bare-metal stent evaluated using intravascular ultrasound and optical frequency domain imaging.
Matsumoto K; Ehara S; Hasegawa T; Sakaguchi M; Yoshikawa J; Shimada K
Cardiovasc Interv Ther; 2017 Apr; 32(2):159-164. PubMed ID: 26983634
[TBL] [Abstract][Full Text] [Related]
40. Late-acquired incomplete stent apposition: morphologic characterization.
Hur SH; Ako J; Honda Y; Sudhir K; Fitzgerald PJ
Cardiovasc Revasc Med; 2009; 10(4):236-46. PubMed ID: 19815171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
